{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:04:57Z","timestamp":1790723097099,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["81112"],"award-info":[{"award-number":["81112"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neulet.2015.02.028","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T17:32:53Z","timestamp":1423848773000},"page":"36-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum"],"prefix":"10.1016","volume":"591","author":[{"given":"Ana C.","family":"Andreazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilte E.","family":"Barakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salar","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Feresten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Hsuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2015.02.028_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2015.02.028_bib0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0976-500X.114596","article-title":"Metabolic syndrome in schizophrenia: differences between antipsychotic-na\u00efve and treated patients","volume":"4","author":"Chadda","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.neulet.2015.02.028_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2009.04.030","article-title":"Metabolic syndrome and oxidative stress","volume":"47","author":"Ando","year":"2009","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.neulet.2015.02.028_bib0025","first-page":"846","article-title":"Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis","volume":"40","author":"Fischer","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2015.02.028_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1989.tb14918.x","article-title":"Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E","volume":"570","author":"Cadet","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2015.02.028_bib0035","series-title":"Oxidative Stress and Free Radical Damage in Neurology","first-page":"19","article-title":"Why is the nervous system vulnerable to oxidative stress?","author":"Friedman","year":"2011"},{"key":"10.1016\/j.neulet.2015.02.028_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0045","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1460-9568.2012.08130.x","article-title":"Cortical interneurons: immune factors and oxidative stress as early targets for schizophrenia","volume":"35","author":"O'Donnell","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2015.02.028_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neulet.2015.02.028_bib0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","article-title":"Haloperidol- and clozapine-induced oxidative stress in the rat brain","volume":"78","author":"Polydoro","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2015.02.028_bib0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","article-title":"Haloperidol and clozapine but not olanzapine, induced oxidative stress in rat brain","volume":"372","author":"Reinke","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2015.02.028_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","article-title":"Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"41","author":"Pillai","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00213-003-1428-8","article-title":"Reversal of haloperidol-induced orofacial dyskinesia by quercetin: a bioflavonoid","volume":"167","author":"Naidu","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2015.02.028_bib0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","article-title":"Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain","volume":"81","author":"Burger","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2015.02.028_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-007-0956-z","article-title":"Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors","volume":"196","author":"Bishnoi","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2015.02.028_bib0095","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.mp.4002098","article-title":"Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder","volume":"13","author":"Pennington","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-244X-9-17","article-title":"Proteome analysis of schizophrenia patients Wernicke\u2019s area reveals an energy metabolism dysregulation","volume":"9","author":"Martins-de-Souza","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0105","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/JCP.0b013e3181c163ef","article-title":"Management of clozapine-related hepatotoxicity","volume":"29","author":"Keane","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2015.02.028_bib0115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.pnpbp.2010.03.010","article-title":"Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels","volume":"34","author":"Barakauskas","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0120","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neulet.2015.02.028_bib0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2013.07.024","article-title":"Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness","volume":"150","author":"Feresten","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0130","first-page":"1","article-title":"Brain and liver oxidative stress after sertraline and haloperidol treatment in mice","volume":"25","author":"Abdel-Salam","year":"2013","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.neulet.2015.02.028_bib0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neulet.2015.02.028_bib0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.110140","article-title":"Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats","volume":"37","author":"Boyda","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neulet.2015.02.028_bib0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","article-title":"A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model","volume":"34","author":"Boyda","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/DMSO.S51145","article-title":"Hepatic function and the cardiometabolic syndrome","volume":"6","author":"Wiernsperger","year":"2013","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.neulet.2015.02.028_bib0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00004714-199708000-00012","article-title":"Hepatotoxicity of clozapine","volume":"117","author":"Hummer","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2015.02.028_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15622970701361263","article-title":"Isoprostenes as indicators of oxidative stress in schizophrenia","volume":"10","author":"Dietrich-Muszalska","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0165","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia","volume":"32","author":"Kunz","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-3223(97)00282-5","article-title":"Elevated plasma lipid peroxides at the onset of nonaffective psychosis","volume":"43","author":"Mahadik","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pnpbp.2013.02.007","article-title":"Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia","volume":"44","author":"Ramos-Loyo","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0185","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s11064-013-1050-z","article-title":"The effects of ziprasidone: clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison","volume":"38","author":"Dietrich-Muszalska","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2015.02.028_bib0195","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1074\/jbc.R111.283432","article-title":"Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides","volume":"287","author":"Rhee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2015.02.028_bib0200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.freeradbiomed.2014.04.002","article-title":"Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome","volume":"72","author":"Manevich","year":"2014","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.neulet.2015.02.028_bib0205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/ars.2011.4298","article-title":"Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathway","volume":"17","author":"Gan","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.neulet.2015.02.028_bib0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2015.02.028_bib0215","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nut.2005.04.002","article-title":"Comparing rat's to human\u2019s age: how old is my rat in people years?","volume":"21","author":"Quinn","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.neulet.2015.02.028_bib0220","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2015.02.028_bib0225","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.biopsych.2010.11.010","article-title":"Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation","volume":"69","author":"Vernon","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0230","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopsych.2013.09.012","article-title":"Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology","volume":"75","author":"Vernon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2015.02.028_bib0235","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1089\/ars.2010.3646","article-title":"Oxidative stress in schizophrenia: pathogenetic and therapeutic implications","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:18:54Z","timestamp":1759609134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394015001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":47,"alternative-id":["S0304394015001330"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2015.02.028","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2015.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}